| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |